Rožanc Jan, Gradišnik Lidija, Velnar Tomaž, Gregorič Minja, Milojević Marko, Vihar Boštjan, Gole Boris, Maver Uroš
Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia.
Department of Neurosurgery, University Medical Centre Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia.
Biomedicines. 2022 Feb 4;10(2):378. doi: 10.3390/biomedicines10020378.
Mesenchymal stem cells (MSCs) represent the basis of novel clinical concepts in cellular therapy and tissue regeneration. Therefore, the isolation of MSCs from various tissues has become an important endeavour for stem cell biobanking and the development of regenerative therapies. Paravertebral adipose tissue is readily exposed during spinal procedures in children and could be a viable source of stem cells for therapeutic applications. Here, we describe the first case of MSCs isolated from paravertebral adipose tissue (PV-ADMSCs), obtained during a routine spinal surgery on a child. Using quantitative real-time PCR and flow cytometry, we show that PV-ADMSCs have different levels of stem marker expression compared to the MSCs from other sources while having the highest proliferation rate. Furthermore, we evaluate the multipotency of PV-ADMSCs by the three-lineage (adipogenic, osteogenic and chondrogenic) differentiation and compare it to the multipotency of MSCs from other sources. It was found that the PV-ADMSCs have a strong osteogenic potential in particular. Taken together, our data indicate that PV-ADMSCs meet the criteria for successful cell therapy, defined by the International Society for Cellular Therapy (ISCT), and thus, could provide a source of MSCs that is relatively easy to isolate and expand in culture. Due to their strong osteogenic potential, these cells provide a promising basis, especially for orthopaedic applications.
间充质干细胞(MSCs)是细胞治疗和组织再生新临床概念的基础。因此,从各种组织中分离MSCs已成为干细胞生物样本库和再生疗法开发的一项重要工作。儿童脊柱手术中椎旁脂肪组织易于暴露,可能是用于治疗应用的干细胞的可行来源。在此,我们描述了首例从一名儿童常规脊柱手术中获得的椎旁脂肪组织分离出的MSCs(PV-ADMSCs)。通过定量实时PCR和流式细胞术,我们发现与其他来源的MSCs相比,PV-ADMSCs具有不同水平的干细胞标志物表达,同时具有最高的增殖率。此外,我们通过三系(脂肪生成、成骨和软骨生成)分化评估PV-ADMSCs的多能性,并将其与其他来源的MSCs的多能性进行比较。结果发现,PV-ADMSCs尤其具有很强的成骨潜力。综上所述,我们的数据表明,PV-ADMSCs符合国际细胞治疗协会(ISCT)定义的成功细胞治疗标准,因此,可以提供一种相对容易在培养中分离和扩增的MSCs来源。由于其强大的成骨潜力,这些细胞提供了一个有前景的基础,特别是在骨科应用方面。